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Simple Summary: Tumor-associated macrophages (TAMs) are a class of immune cells present in
solid tumors and they are involved in cancer-related inflammation. However, to our knowledge,
literature about TAMs in canine soft tissue sarcomas (STSs) is limited to absent. Here we analyzed
38 STSs retrieved from the veterinary pathology archive. Only STSs arising from limbs and the trunk
were included. Oral, visceral STSs, and tumors mimicking STSs were excluded. TAMs were identified
by means of immunohistochemistry and were counted in 10 consecutive tumors areas, where no
confounding factors such as necrosis or other inflammatory cells could be identified. Associations
between numbers of TAMs and tumor features were investigated. TAMs were evident in all STSs
and ranged between 6% to 62% of the cells in the microscopic field. The number of TAMs positively
correlated with the STSs’ histologic grade. The present findings suggest that TAMs are present in
higher numbers when STSs are of aggressive histological grade and especially in those with a high
number of proliferating cancer cells. The abundant presence of TAMs in high grade STSs may also
increase the likelihood of a pathologist misdiagnosing STS for tumors where macrophages are the
actual cancerous component, such as histiocytic sarcomas.
Abstract: Tumour-associated macrophages (TAMs) are an important part of the tumour microen-
vironment but knowledge of their distribution in canine soft tissue sarcomas (STSs) is limited to
absent. We analysed 38 STSs retrieved from the veterinary pathology archive; oral and visceral
STSs, synovial cell sarcoma, tumours of histiocytic origin, haemangiosarcoma, carcinosarcomas,
and undifferentiated tumours were excluded. Iba-1 positive, non-neoplastic tumour infiltrating
cells (morphologically indicative of macrophages) were classified as TAMs and were counted in
10 consecutive tumours areas, where no necrosis or other inflammatory cells could be identified.
Associations between numbers of TAMs and mitoses, differentiation, and necrosis scores or grade
were investigated. TAMs were evident in all STSs and ranged between 6% to 62% of the cells in
the microscopic field. The number of TAMs positively correlated with the STSs’ histologic grade.
When the components of the grade were analysed separately, TAMs were statistically correlated with
mitoses, but not with differentiation or necrosis score. The present findings suggest that TAMs are
present in higher numbers when STS proliferation is the predominant feature that drives tumour
grade. The abundant presence of TAMs in high-grade STSs may also increase the likelihood of a
pathologist misdiagnosing STS for histiocytic sarcoma.
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1. Introduction
Non-resolving inflammation is one of the hallmarks of cancer, and among inflamma-
tory cells, tumor-associated macrophages (TAMs) represent probably the most relevant
component of the leucocytes infiltrate [1–3]. TAMs are derived from peripheral blood
monocytes that have been recruited by chemokines; these can be divided into selectively
activated (M2) and classically activated (M1) macrophages [1,3,4]. M2 macrophages are
mainly activated by helper T-cell (Th) 2 secreted cytokines (such as interleukin (IL)-4, IL-10,
and IL-13) and are thought to play a relevant role in cancer initiation and promotion,
immune suppression, metastasis, and angiogenesis [1,3]. Conversely, M1 macrophages are
primarily considered as “tumoricidal”, being physiologically involved in helper T-cell (Th)
1 responses to infection, the production of pro-inflammatory cytokines and phagocytize
microbes, initiating an immune response and being mainly activated by interferon-γ or
lipopolysaccharide [1,3].
In human oncology, numerous studies have demonstrated that a high number of
infiltrating TAMs with M2 phenotype represent a negative prognostic factor in various
tumors: non-gynecologic leiomyosarcomas, gastric cancer, urogenital cancer, head and
neck cancer, lymphomas, and cholangiocarcinoma [3,5]. On the contrary, tumor infiltration
by macrophages with M1 phenotype seem to favor a better prognosis in non-small cell
lung cancer and ovarian cancer [5,6], among others. However, this is not always the case as
M2 TAMs have also been associated with lower tumor stages and/or improved survival
in tumors such as Ewing sarcoma and colorectal carcinomas [7,8]. Overall, differentiation
among TAMs of the M1 and M2 phenotype is not straightforward as there is still a lack of
definitive surface markers for M1 macrophages and a lack of markers’ specificity for M2
macrophages [4,8,9]. It appears that the distinction between M1 and M2 may not be strictly
relevant and that the overall degree of TAM infiltration within the tumor might be more
important; accumulating evidence is suggesting overlapping features that depend on the
mix of signals in their direct microenvironment [10,11].
The interest in TAMs has been also increasing in veterinary oncology where studies
have mainly focused on mammary carcinomas and on colorectal carcinoma [12–17].
The aim of this study was to characterize the presence of TAMs in an heterogenous
population of canine soft tissue sarcomas (STSs) and to analyze their relationship with
tumor morphological features. For the purpose of this study, TAMs were identified as
Iba-1 positive, non-neoplastic, tumor infiltrating cells [16]. The whole TAM population
was analyzed, without differentiating between M1 and M2. We hypothesized that there
would be an association between the presence of TAMs and tumor grading.
2. Materials and Methods
2.1. Samples
Pathology records of canine STSs submitted to the Section of Veterinary Pathology of
the Department of Veterinary Anatomy, Physiology and Pathology of Liverpool University
(UK), between January 2016 to December 2019, were searched in a computerized database.
STSs excised for diagnostic and/or therapeutic purposes were included in the dataset.
Cases were considered eligible for the study only if formalin fixed paraffin-embedded
(FFPE) tissues were available for review and if neoplastic cells stained positive for vimentin,
and negative for the calcium-binding adapter molecule 1 (Iba-1), Von Willebrand factor,
and pan-cytokeratin.
Carcinosarcomas, oral and visceral STSs, as well as mesenchymal tumors such as syn-
ovial cell sarcoma, tumors of histiocytic origin, haemangiosarcoma, and undifferentiated
tumors were excluded.
Patient’s signalment and clinical data were retrieved from the submission forms/patient
files; dogs were excluded from the study if they were known to have received steroids, non-
steroidal anti-inflammatory drugs, and/or antineoplastic chemotherapy within a month
prior to the tissue collection.
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2.2. Histopathology and Immunohistochemistry
All histological slides were reviewed by a board-certified veterinary pathologist (LR).
Slides were given a consecutive number so that the pathologist was blinded to the original
pathology report and tumor/patient data (e.g., first or second opinion, tumor subtype and
grade patient history, signalment, among others).
The slides were originally prepared from FFPE tissues fixed in 10% neutral buffered
formalin, were routinely stained with hematoxylin and eosin (HE), and were observed
under a bright field upright microscope. Samples were assessed and graded following
previous recommendations for the diagnosis of canine STS [18]. Briefly, assessed tumor
areas were not overly complicated by inflammation and/or hemorrhage, as if so they were
deselected. Differentiation represented the true differentiation of the tumor—uncertainty re-
garding histogenesis had no bearing on degree of differentiation [18]; sarcomas resembling
adult normal tissue were given Score 1, sarcomas where the cell type could be determined
but differentiation was poor were given Score 2, and sarcomas with a high degree of atypia
(e.g., anisokaryosis and anisocytosis) where the origin was not determinable were given
Score 3. Mitotic index (MI) was assessed within the most cellular part of the tumor and the
area with the highest mitotic activity. The MI was calculated as the total number of mitotic
figures in 10 tumor (microscopic 400×; ocular FN: 22; objective 40×/0.65) high-power
fields (HPFs). According to STS grade, the number of mitoses in 10 high power fields
was semi-quantitatively assessed using three scores: 0–9 mitoses (Score1), 10–19 mitoses
(Score 2), >19 mitoses (Score 3). Necrosis was evaluated over the whole tumor sample
present on the section, based on the % of area occupied by the necrotic process. A score
was given as follows: no necrosis (Score 0), <50% of the tumor area as necrotic (Score 1),
>50% of the tumor area as necrotic (Score 2).
All the scores obtained from the three different assessments (differentiation, mitoses,
necrosis) were summed, and Grade was determined as follows: Grade 1 (Score < 3); Grade 2
(Score 4 or 5), Grade 3 (Score 6 or above) [18].
Representative sections of the lesions were selected for immunohistochemistry (IHC).
All sections were deparaffinized in xylene and hydrated with graded ethanol concentration
up to distilled water. Antigen retrieval was performed by calibrated water bath capable
of maintaining the epitope retrieval solution in 10 mM sodium citrate buffer (pH 6.0) at
97 ◦C for 30 min (Agilent technologies Ltd., Stockport, UK). The sections were allowed
to cool down to room temperature for 20 min. Endogenous peroxidase was blocked
using 100 µL Dako REALTM peroxidase blocking solution for 10 min (Agilent technologies
Ltd., Stockport, UK). The following primary antibodies were selected: vimentin (Dako,
mouse monoclonal, clone V9), Iba1 (Abcam, goat polyclonal, AB5076), Von Willebrand
factor (Dako, rabbit polyclonal, A0082), and pan-cytokeratin (AE1/AE3/PCK26, Mouse
monoclonal, Ready to use, Ventana). The bound antibody was evaluated by peroxidase
conjugated polymers (Anti Mouse/Rabbit Envision Flex+, Agilent Technologies Ltd.;
Agilent technologies Ltd., Stockport, UK or ImmPress anti Goat, Vector Laboratories,
Burlingame, CA, USA) for 30 min and diaminobenzidine tetrahydrochloride was used as a
detection system (DAB—Agilent Technologies Ltd., Stockport, UK). Upon completion of
the immunostaining, sections were counterstained with Mayer’s hematoxylin. A normal
canine lymph node was used as a positive control for Iba1 (nodal macrophages), vimentin
(nodal stroma), and Von Willebrand factor (endothelium of the nodal vessels) antibodies; a
section of normal skin was used as a positive control for pan-cytokeratin (epidermis). The
negative control consisted of the substitution of the primary antibody with isotype-matched
murine immunoglobulin or normal serum from rabbit/goat, depending on the primary
antibody isotype. Tumor infiltrating, non-neoplastic, Iba-1 positive cells were considered
as TAMs.
Statistical association between number of TAMs and mitoses, necrosis scores, and
tumor grade, was investigated using the Mann–Whitney test. Statistical analysis was
performed using SPSS 13 Software (SPSS 13.0, SPSS Inc, IBM, Chicago, IL, USA).
Animals 2021, 11, 684 4 of 8
3. Results
Cases studied were gathered from 19 male and 19 female dogs, with a median age of
114.5 months (range: 12–168). There were 12 cross-breeds, 3 boxers, 3 Labrador retrievers,
2 border collies, 2 Doberman pinchers, 2 French bulldogs, and one each of the following
breeds: bulldog, bull terrier, Cavalier King Charles spaniel, cocker spaniel, flat coated
retriever, golden retriever, Jack Russel terrier, miniature schnauzer, Patterdale terrier, pit
bull, Romanian shepherd, English setter, springer spaniel, and Staffordshire bull terrier.
The locations of the neoplasms were as follows: limbs (17), trunk (15), and head and neck
(6). Seven STSs were Grade 1, 13 were Grade 2, and 18 were Grade 3 (Table 1).
Iba1 immunohistochemistry successfully stained TAMs infiltrating within the STSs
studied; these exhibited a predominant pleomorphic morphology with several dendritic-
like cytoplasmic elongation, which embraced neoplastic cells (Figure 1a,b).
Figure 1. Morphological features of TAMs in canine soft tissue sarcoma, and their associations with grade.
(a) Iba1-positive TAMs in a case with moderate TAM infiltration. Inset: often TAM exhibited dendritic-like
cytoplasmic elongations. Scale bar: 50 microns, indirect immunoperoxidase. (b) Iba1-positive TAMs in
a case with marked TAM infiltration. Scale bar: 50 microns; indirect immunoperoxidase. (c) Significant
difference (“*”) in the median of % of TAM infiltration in different Grades. Scale bar: 50 microns; indirect
immunoperoxidase. (d) Linear correlation between the average number of mitoses in 10 high-power fields
(HPFs) and % of TAM infiltration. (e) Significant difference (“*”) in the median of % of TAM infiltration
in different Grades considering only mitoses as grade component. (f) Lack of significant difference in
the median of % of TAM infiltration in different Grades considering only necrosis as grade component.
(g) Lack of significant difference in the median of % of TAM infiltration in different Grades considering
only differentiation as grade component.
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Doberman pincher 64 Female Limb 1
Miniature schnauzer 72 Female Head and Neck 1
Border collie 120 Male Limb 1
Cavalier King Charles spaniel 120 Male Limb 1
Cross-breed 110 Female Trunk 1
Labrador retriever 120 Female Trunk 1
Border collie 129 Male Limb 1
Doberman pincher 12 Female Limb 2
Labrador retriever 57 Male Head and Neck 2
Cross-breed 120 Male Trunk 2
Cross-breed 132 Female Limb 2
Cross-breed 120 Female Trunk 2
Cross-breed 143 Male Head and Neck 2
Boxer 146 Female Limb 2
Cross-breed 120 Female Limb 2
Cross-breed 96 Female Limb 2
Boxer 114 Female Limb 2
French bulldog 84 Male Head and Neck 2
Cross-breed 120 Female Limb 2
Staffordshire bull terrier 96 Male Limb 2
Cocker spaniel 132 Male Trunk 3
Cross-breed 84 Male Trunk 3
Bulldog 60 Male Trunk 3
Boxer 24 Female Trunk 3
Bull terrier 132 Male Limb 3
Springer spaniel 168 Male Trunk 3
English setter 115 Female Limb 3
French bulldog 96 Male Head and Neck 3
Patterdale terrier 144 Female Head and Neck 3
Jack Russel terrier 115 Male Trunk 3
Romanian shepherd 36 Female Limb 3
Golden retriever 81 Female Trunk 3
Flat-coated retriever 84 Female Trunk 3
Labrador retriever 144 Male Trunk 3
Pit bull 76 Male Trunk 3
Cross-breed 132 Male Limb 3
Cross-breed 100 Female Limb 3
Cross-breed 96 Male Trunk 3
The amount of TAMs, evaluated by the average percentage of Iba1 positive areas,
varied widely between the tumours (median 21%; range 5–62%). When the percentage of
positive TAMs of the STSs studied was associated with grade, a statistical association was
detected (p < 0.05; Figure 1c).
Investigating the possible association with TAM infiltration and each of the com-
ponents of the STS grade (mitoses, differentiation, and percentage of necrosis), only
the mitotic index was found to be positively associated with the three grade categories
(Figure 1c,e–g). There was a linear association between mitoses and the percentage of
the area occupied by TAMs (Figure 1d). No associations were found between TAMs
and the age, sex, or tumour location.
4. Discussion
In the present study TAMs were investigated in canine STSs with the aid of Iba1
immunohistochemistry. The morphology of the cells was predominantly pleomorphic
as expected from histiocytic cells, with occasional slender elongations, which suggest a
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contact with tumor cells. The most relevant finding of the present study is the association
between the area occupied by TAMs and mitotic activity of the tumor. After unbundling
the different descriptor of STS grading (differentiation, mitoses, necrosis), mitotic activity
was the one only factor associated with TAMs. This may agree with the suggestion of some
authors that TAMs are a prognostic indicator, and the higher the levels within the tumor
the poorer the prognosis [19].
It is a common notion that TAMs are involved in the progression of tumors, however,
the mechanism for tumor recruitment and the functions that allow these cells to help the
tumor progressing are not fully understood [19]. Raposo et al. (2014) discuss in their
article that TAMs have an important role in angiogenesis helping the sarcoma to proliferate.
Similarly, TAMs are being reported to support carcinogenesis and tumor progression,
which would concur with the findings of this study that the more TAMs present the higher
the level of mitotic figures in tumor cells [13]. Similar findings have been reported by
Valković et al. in human invasive ductal breast cancer, who noted that neoplastic lesions
with a great number of TAMs had significantly higher mitotic activity than tumors with no
or just a small focus of macrophages [20].
Conversely, we also consider alternative hypotheses for the correlation between the
two factors. It could be possible that high levels of TAMs are attracted by the proliferating
cells and proportional to their number in attempt to mitigate such proliferation or without
any biological further action. Since no functional studies are available that investigate the
insights of these mechanisms, this remains an association to further explore. The results of
this study do not clarify a positive or negative mechanistic effect of TAMs in canine soft
tissue sarcomas.
Using TAMs as a therapeutic target is a well discussed topic. TAMs stimulate angio-
genesis as a response to hypoxic conditions, which are in part a result of cancer therapies;
therefore, having a potential negative effect on therapeutic attempts [13]. Targeting these
macrophages might lead to better attempts at therapy as these cells would no longer be
“defending” the tumor. Some authors suggest that directly targeting TAMs is in itself
cancer therapy and new ways of carrying this out are being currently investigated [19].
Franklin et al. noted that when certain signaling proteins are prevented, the differentiation
of TAMs is blocked. This depletion then led to a reduced metastatic rate and increased the
potential of T cytotoxic lymphocytes to suppresses tumor growth [21]. More recent human
studies have clarified the heterogeneity and complexity of the immune microenvironment
and the pervasive immunosuppressive niche sustained by TAMs, which may be overcome
with the activation of T cells that traffic into STSs [22]. Overall, it appears that therapeutic
success may be significantly improved by the development of a more effective combination
of chemo-immunotherapies in STSs [23].
A still complex topic is to clarify if a difference exists between tissue resident macrophages
that happen to infiltrate the tumor in a site, or distant recruited macrophages that infiltrate
a specific tumor site. Researchers such as Franklin et al. and Wu et al. suggest that tissue
resident macrophages have little effect on tumor burden and overall malignancy, and that
some even suppress tumor advancement [21,24]. An example is microglia in the brain, which
according to Sarkar et al. suppresses brain tumor initiating cells during tumorigenesis or
relapse of gliomas [25]. In contrast to this, Wu et al. describe how resident Kupffer cells
in the liver can be shown to promote the progression of hepatocarcinoma [24]. This is still
a complex field and more research needs to be conducted to ensure the correct molecular
characterization of macrophages to determine whether they are TAMs recruited at distance or
resident tissue associated macrophages [26]. In our study we have not differentiated between
resident and distantly recruited macrophages, but we have instead considered the whole
population of TAMs as per pattern of infiltration and Iba1 positivity [16].
While TAMs are at the forefront of many investigations into metastatic tumors, re-
search focusing on soft tissue sarcomas is limited. There are human models based on lung
cancer and mammary tumors in canines, of which principles are transferable [13,14,27].
However, it should be noted that there is a vast array of research on this matter in human
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patients, but limited information is available in the veterinary field. More research in the
veterinary field may find different results than those that are presented in the human field
as in previous cases.
A limitation of the present study is the lack of further characterization of TAMs into
M1 and M2 subtypes; however, the liner correlation observed between iba1 positive cells
and mitotic activity (and ultimately grading) represents a relevant finding.
5. Conclusions
Results of this study suggest that that distinction between M1 and M2 might be more
important than the overall presence of TAMs within the tumor, as supported by other
authors [10,11]. It is the opinion of the authors that STSs with high number of TAMs may
pose a significant challenge to pathologists, with the potential of being misdiagnosed for
histiocytic sarcomas, and caution should be made during interpretation of HE and IHC
slides. Further studies are warranted to investigate the biological mechanisms of TAMs in
canine sarcomas.
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